Impact BioMedical Inc. (IBO)
NYSEAMERICAN: IBO · Real-Time Price · USD
0.4580
-0.0120 (-2.55%)
Dec 5, 2025, 4:00 PM EST - Market closed
Impact BioMedical Market Cap
Impact BioMedical has a market cap or net worth of $47.92 million as of December 5, 2025. Its market cap has increased by 65.95% in one year.
Market Cap
47.92M
Enterprise Value
70.79M
1-Year Change
65.95%
Ranking
Category
Stock Price
$0.46
Market Cap Chart
Since the IPO on September 16, 2024, Impact BioMedical's market cap has increased from $34.49M to $47.92M, an increase of 38.92%. That is a compound annual growth rate of 30.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 47.92M | 187.26% |
| Dec 31, 2024 | 16.68M | -51.64% |
| Sep 16, 2024 | 34.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |